SB 422 — Health Care - As introduced, lowers from every three years to every two years, the time within which the advisory committee composed of medical device industry representatives and a representative of the department of economic and community development must review rules regarding the board of pharmacy's oversight of facilities that manufacture, warehouse, and distribute medical devices in order to review the advancements of new medical device technologies. - Amends TCA Title 8; Title 47; Title 56; Title 63 and Title 71.

SB 422 (Amendment HA0557)

Amendment HA0557 text of SB 422.

House Insurance 1

Amendment No. 1 to HB0406

The document summary and details above are public. The full text is available to signed-in accounts.